News
Wiewelhove News
Statement for Extension of the GMP certificate
The GMP certificates of the company Wiewelhove GmbH for the site Gildstr.4, Gildestr. 39 and Wilhelmstr. 248 will be invalid on 09th of June 2025. The routine surveillance inspection is planned for 19th & 20th of August 2025. Until the planned inspection is performed our authority has issued a statement for this timeframe.
You`ll find the statement on our homepage via Company → downloads
FDA Inspection
In October 2024, Wiewelhove successfully passed an FDA inspection for food supplements for the first time in its quality history.
The 5-day inspection was completed with the result “NAI” No Action Indicated.
CPHI 2024 - We were there 🌍.
From left to right: Henning Wientke (Managing Director), Ricarda Boße (Sales Manager Nadine Berelsmann (Deputy head of Galenical Development), Lukas Meyer (Head of Regulatory Compliance), Dieter Brillert (Head of Quality Control), Till Strecke (Purchase Raw Materials), Carolin Plagemann (Managing Director), Dr. Peter Döbber (Managing Director), Patrick Bergermann (Deputy Head of Sales)
This year, we were once again present at CPHI - one of the world's largest and most important trade fairs for the pharmaceutical industry.💊
Every year, CPHI brings together leading companies, experts and professionals from all over the world to discuss innovations, new technologies and future trends in the pharmaceutical industry.
For us, taking part in this event is always a great opportunity to make valuable contacts, learn about the latest developments and present our own innovative solutions.